Kidney Week Educational Symposia-B-Cell Therapy over a Patient's Lifetime: When and Where to Deploy It in Lupus Nephritis and Membranous Nephropathy

Video Transcription

Video Summary

<strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Moderator(s):</strong><span style="color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff; float: none; display: inline;"> David Salant</span><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Presentation(s):</strong><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" />
<ul style="box-sizing: border-box; margin-top: 0px; margin-bottom: 10px; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Introduction</strong> - David Salant</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Immunopathogenesis of Lupus Nephritis and Membranous Nephropathy: From Mechanisms to Therapeutic Targets</strong> - Samir Parikh</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">B-Cell Therapy During Induction, Maintenance, and Relapse in Lupus Nephritis and Membranous Nephropathy</strong> - Salem Almaani</li>
</ul>
<br /><em style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Support is provided by an educational grant from Genentech, a member of the Roche Group.</em>&nbsp;

Asset Subtitle

Moderator(s): David Salant

Presentation(s):

Introduction - David Salant
Immunopathogenesis of Lupus Nephritis and Membranous Nephropathy: From Mechanisms to Therapeutic Targets - Samir Parikh
B-Cell Therapy During Induction, Maintenance, and Relapse in Lupus Nephritis and Membranous Nephropathy - Salem Almaani

Support is provided by an educational grant from Genentech, a member of the Roche Group.

Meta Tag

Pathway(s) Glomerular Diseases

Pathway(s) Pharmacology

Session Type ES - Educational Symposium

Speaker(s) David Salant

Speaker(s) Samir Parikh

Speaker(s) Salem Almaani

Keywords

lupus nephritis

membranous nephropathy

B-cell therapy

rituximab

obinutuzumab

PLA2R antibodies

BAFF

APRIL

plasma cells

immunopathogenesis

Therapeutic Targets

Induction Therapy

Maintenance Therapy

Relapse Treatment

Nephrology

Genentech